Laponis Adam 4

What Happened
Adam Laponis, Chief Financial Officer of Twist Bioscience (TWST), reported a sale of 3,000 shares on April 14, 2026. The shares were disposed at $55.00 per share for a total transaction value of $165,000. The filing lists the sale as an "open market or private sale."

Key Details

• Transaction date: 2026-04-14; Price: $55.00; Shares sold: 3,000; Proceeds: $165,000.
• Report filed with the SEC on 2026-04-16 (two days after the transaction) — appears timely under Form 4 rules.
• Footnote: Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025.
• Shares owned after the transaction: not specified in the provided filing excerpt — see the full Form 4 for current holdings.

Context
This was a sale (not a purchase or option exercise). Sales executed under a pre-existing 10b5-1 trading plan are typically scheduled in advance and do not necessarily reflect an insider’s current view of the company; they are considered routine by many investors. For complete ownership and any additional details, consult the full SEC Form 4 (Accession No. 0001214659-26-004735).